337 related articles for article (PubMed ID: 24211451)
1. Temporal and spectral differences in the ultrasonic vocalizations of fragile X knock out mice during postnatal development.
Lai JK; Sobala-Drozdowski M; Zhou L; Doering LC; Faure PA; Foster JA
Behav Brain Res; 2014 Feb; 259():119-30. PubMed ID: 24211451
[TBL] [Abstract][Full Text] [Related]
2. Reversal of ultrasonic vocalization deficits in a mouse model of Fragile X Syndrome with minocycline treatment or genetic reduction of MMP-9.
Toledo MA; Wen TH; Binder DK; Ethell IM; Razak KA
Behav Brain Res; 2019 Oct; 372():112068. PubMed ID: 31271818
[TBL] [Abstract][Full Text] [Related]
3. Sex-specific modulation of early life vocalization and cognition by Fmr1 gene dosage in a mouse model of Fragile X Syndrome.
Giua G; Iezzi D; Caceres-Rodriguez A; Strauss B; Chavis P; Manzoni OJ
Biol Sex Differ; 2024 Feb; 15(1):18. PubMed ID: 38383408
[TBL] [Abstract][Full Text] [Related]
4. Spectral and temporal properties of calls reveal deficits in ultrasonic vocalizations of adult Fmr1 knockout mice.
Hodges SL; Nolan SO; Reynolds CD; Lugo JN
Behav Brain Res; 2017 Aug; 332():50-58. PubMed ID: 28552599
[TBL] [Abstract][Full Text] [Related]
5. High-throughput analysis of vocalizations reveals sex-specific changes in Fmr1 mutant pups.
Nolan SO; Hodges SL; Lugo JN
Genes Brain Behav; 2020 Feb; 19(2):e12611. PubMed ID: 31587487
[TBL] [Abstract][Full Text] [Related]
6. Characterization of ultrasonic vocalizations of Fragile X mice.
Belagodu AP; Johnson AM; Galvez R
Behav Brain Res; 2016 Sep; 310():76-83. PubMed ID: 27142239
[TBL] [Abstract][Full Text] [Related]
7. Sex-specific and genotype-specific differences in vocalization development in FMR1 knockout mice.
Reynolds CD; Nolan SO; Jefferson T; Lugo JN
Neuroreport; 2016 Dec; 27(18):1331-1335. PubMed ID: 27824730
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of ultrasonic vocalizations in a mouse model of fragile X syndrome reveals limited, call type specific deficits.
Roy S; Watkins N; Heck D
PLoS One; 2012; 7(9):e44816. PubMed ID: 22984567
[TBL] [Abstract][Full Text] [Related]
9. Minocycline treatment reverses ultrasonic vocalization production deficit in a mouse model of Fragile X Syndrome.
Rotschafer SE; Trujillo MS; Dansie LE; Ethell IM; Razak KA
Brain Res; 2012 Feb; 1439():7-14. PubMed ID: 22265702
[TBL] [Abstract][Full Text] [Related]
10. A single episode of early-life status epilepticus impacts neonatal ultrasonic vocalization behavior in the Fmr1 knockout mouse.
Huebschman JL; Hodges SL; Reynolds CD; Nolan SO; Lugo JN
Epilepsy Behav; 2020 Oct; 111():107279. PubMed ID: 32693376
[TBL] [Abstract][Full Text] [Related]
11. Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome.
Spencer CM; Alekseyenko O; Serysheva E; Yuva-Paylor LA; Paylor R
Genes Brain Behav; 2005 Oct; 4(7):420-30. PubMed ID: 16176388
[TBL] [Abstract][Full Text] [Related]
12. Multiple Early-Life Seizures Alters Neonatal Communicative Behavior in Fmr1 Knockout Mice.
Nguyen PH; Narvaiz DA; Womble PD; Sullens DG; Binder MS; Hodges SL; Kwok E; Lugo JN
Dev Neurosci; 2022; 44(6):478-486. PubMed ID: 35512644
[TBL] [Abstract][Full Text] [Related]
13. Regional brain volumes changes in adult male FMR1-KO mouse on the FVB strain.
Lai JK; Lerch JP; Doering LC; Foster JA; Ellegood J
Neuroscience; 2016 Mar; 318():12-21. PubMed ID: 26794591
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of Autism-associated genes in the brain of Fragile X mouse model.
Zhang A; Shen CH; Ma SY; Ke Y; El Idrissi A
Biochem Biophys Res Commun; 2009 Feb; 379(4):920-3. PubMed ID: 19138667
[TBL] [Abstract][Full Text] [Related]
15. The effects of repeated early deprivation on ultrasonic vocalizations and ontogenetic development in mandarin vole pups.
Yu P; Wang J; Tai F; Broders H; An S; Zhang X; He F; An X; Wu R
Behav Processes; 2011 Nov; 88(3):162-7. PubMed ID: 21925576
[TBL] [Abstract][Full Text] [Related]
16. Fmr1 knockout mice are impaired in a leverpress escape/avoidance task.
Brennan FX; Albeck DS; Paylor R
Genes Brain Behav; 2006 Aug; 5(6):467-71. PubMed ID: 16923151
[TBL] [Abstract][Full Text] [Related]
17. Delayed myelination in a mouse model of fragile X syndrome.
Pacey LK; Xuan IC; Guan S; Sussman D; Henkelman RM; Chen Y; Thomsen C; Hampson DR
Hum Mol Genet; 2013 Oct; 22(19):3920-30. PubMed ID: 23740941
[TBL] [Abstract][Full Text] [Related]
18. Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins.
Spencer CM; Serysheva E; Yuva-Paylor LA; Oostra BA; Nelson DL; Paylor R
Hum Mol Genet; 2006 Jun; 15(12):1984-94. PubMed ID: 16675531
[TBL] [Abstract][Full Text] [Related]
19. Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice.
Michalon A; Bruns A; Risterucci C; Honer M; Ballard TM; Ozmen L; Jaeschke G; Wettstein JG; von Kienlin M; Künnecke B; Lindemann L
Biol Psychiatry; 2014 Feb; 75(3):189-97. PubMed ID: 23910948
[TBL] [Abstract][Full Text] [Related]
20. Age-specific autistic-like behaviors in heterozygous Fmr1-KO female mice.
Gauducheau M; Lemaire-Mayo V; D'Amato FR; Oddi D; Crusio WE; Pietropaolo S
Autism Res; 2017 Jun; 10(6):1067-1078. PubMed ID: 28301083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
